Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Catalyst Grant: Health Effects of Vaping

University of British Columbia

$25,000.00

Effects of ecigarettes on lung health: The VAPE Study (Vaping's Airway and Lung Parenchymal Effects)

EF 2020-21

Résumé
Canada is experiencing a surge in use of ecigarettes especially among its youth. ~15% of Canadians (or 4.6 million Canadians) have used vaping products. The fastest growing user-groups are youths aged 15 and 19 and young adults aged 20 to 24 (prevalence, 23%-29%), In most cases (>80%), e-cigarettes contain nicotine as the active ingredient. Other active ingredients include tetrahydrocannabinol (THC), cannabinoid oils and synthetic drugs. In Canada, 18 cases of e-cigarette product use-associated lung injury (or EVALI) have been reported with most coming from British Columbia (4), Ontario (4) and Quebec (6), The pathogenesis of lung injury related to vaping is largely unknown. We believe that chronic use of e-cigarettes leads to molecular injuries to airways, which predisposes these individuals to lung diseases including EVALI, COPD, lung cancer and pneumonia and that these changes can be detected using novel imaging and bronchoscopic techniques. The VAPE Study will be a prospective 1-year study that will evaluate the effects of e-cigarettes on lung health. The study will contain 2 active arms: 1) users of nicotine containing e-cigarettes; and 2) users of THC containing e-cigarettes. As controls, we will enroll: 1) current cannabis smokers ONLY; 2) combined tobacco and cannabis smokers; 3) current tobacco smokers ONLY; and 4) Never smokers of tobacco or cannabis and non-vape users. Through this study, we will determine the potential harmful effects of ecigarettes in the airways and identify strategies to mitigate the risk of EVALI and other clinical consequences related to vaping.
Programme
Catalyst Grant: Health Effects of Vaping
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
424228
Name
Sin Donald
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Cancer Society - National Office (Toronto)
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Catalyst Grant : Health Effects of Vaping
Projecttitle
Effects of ecigarettes on lung health: The VAPE Study (Vaping's Airway and Lung Parenchymal Effects)
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$25,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Health Effects of Vaping
Keyworddelim
Airway; Evali; Lung
Abstract
Canada is experiencing a surge in use of ecigarettes especially among its youth. ~15% of Canadians (or 4.6 million Canadians) have used vaping products. The fastest growing user-groups are youths aged 15 and 19 and young adults aged 20 to 24 (prevalence, 23%-29%), In most cases (>80%), e-cigarettes contain nicotine as the active ingredient. Other active ingredients include tetrahydrocannabinol (THC), cannabinoid oils and synthetic drugs. In Canada, 18 cases of e-cigarette product use-associated lung injury (or EVALI) have been reported with most coming from British Columbia (4), Ontario (4) and Quebec (6), The pathogenesis of lung injury related to vaping is largely unknown. We believe that chronic use of e-cigarettes leads to molecular injuries to airways, which predisposes these individuals to lung diseases including EVALI, COPD, lung cancer and pneumonia and that these changes can be detected using novel imaging and bronchoscopic techniques. The VAPE Study will be a prospective 1-year study that will evaluate the effects of e-cigarettes on lung health. The study will contain 2 active arms: 1) users of nicotine containing e-cigarettes; and 2) users of THC containing e-cigarettes. As controls, we will enroll: 1) current cannabis smokers ONLY; 2) combined tobacco and cannabis smokers; 3) current tobacco smokers ONLY; and 4) Never smokers of tobacco or cannabis and non-vape users. Through this study, we will determine the potential harmful effects of ecigarettes in the airways and identify strategies to mitigate the risk of EVALI and other clinical consequences related to vaping.
Competitiondate
202006
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sin, Donald
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Cancer Research~ $25,000~ $0~